Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03366220 · ClinicalTrials.gov registry record · Phase 2
Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT03366220 is a Phase 2 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 16 participants.
The verdict
NCT03366220, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
There is a knowledge gap regarding the optimal initial fluid to achieve effective resuscitation and improved outcomes in septic shock. The purpose of this study is to compare initial resuscitation with plasma to initial resuscitation with balanced crystalloids.
Interventions
- DRUG Plasma
- DRUG Balanced crystalloids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2019-10-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03366220
The ClinicalTrials.gov registry entry for NCT03366220 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Plasma is the first listed.
NCT03366220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03366220 about?
NCT03366220 is a clinical study titled "Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock". There is a knowledge gap regarding the optimal initial fluid to achieve effective resuscitation and improved outcomes in septic shock. The purpose of this study is to compare initial resuscitation with plasma to initial resuscitation with balanced crystalloids.
What is the current status of trial NCT03366220?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2018-03-26. Estimated completion is 2019-10-16.
What interventions are being tested in trial NCT03366220?
The interventions under investigation include: Plasma (DRUG), Balanced crystalloids (DRUG).
Who is sponsoring clinical trial NCT03366220?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.